JHC Systems Limited Revenue and Competitors
Estimated Revenue & Valuation
- JHC Systems Limited's estimated annual revenue is currently $275.8M per year.
- JHC Systems Limited's estimated revenue per employee is $294,000
Employee Data
- JHC Systems Limited has 938 Employees.
JHC Systems Limited's People
| Name | Title | Email/Phone |
|---|
JHC Systems Limited Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $55.7M | 241 | -24% | N/A | N/A |
#2 | $12.5M | 66 | -3% | N/A | N/A |
#3 | $3.4M | 23 | 0% | N/A | N/A |
#4 | $16.2M | 77 | 28% | N/A | N/A |
#5 | $48M | 208 | 2% | N/A | N/A |
#6 | $85.1M | 324 | 19% | N/A | N/A |
#7 | $88.2M | 336 | 40% | N/A | N/A |
#8 | $411M | 1398 | 17% | N/A | N/A |
#9 | $105.3M | 401 | 55% | N/A | N/A |
#10 | $105.9M | 397 | 5% | $878.2M | N/A |
What Is JHC Systems Limited?
N/A
Total Funding
938
Number of Employees
$275.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
JHC Systems Limited News
... China), the blots were visualized by ChemiDoc XRS+ system (Bio-rad ... LTD. (Shanghai, China). Stable HCCLM3 cells were established by...
... up by telephone or medical record system for overall survival (OS). ... the radiomics platform (Huiying Medical Technology Co., Ltd).
The management of HCC is mainly based on a staging system for liver cancer with ... limited efficacy only in vivo or in vitro HCC models.
The financial technology company FNZ announced that it acquired JHC Systems Ltd (JHC), UK-based software provider to the wealth management industry. FNZ is a global fintech firm that partners with banks, insurers, and asset managers and is responsible for more than £380 billion in assets under ...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $288.9M | 938 | 9% | N/A |
#2 | $289.2M | 939 | 80% | N/A |
#3 | $35M | 940 | 64% | N/A |
#4 | $158.3M | 942 | 7% | N/A |
#5 | $320.8M | 943 | 6% | N/A |